Milestone Pharmaceuticals (MIST) Net Cash Flow: 2018-2024
Historic Net Cash Flow for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to $11.6 million.
- Milestone Pharmaceuticals' Net Cash Flow fell 1192.08% to -$29.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$106.5 million, marking a year-over-year decrease of 354.61%. This contributed to the annual value of $11.6 million for FY2024, which is 88.67% up from last year.
- Milestone Pharmaceuticals' Net Cash Flow amounted to $11.6 million in FY2024, which was up 88.67% from $6.1 million recorded in FY2023.
- Milestone Pharmaceuticals' 5-year Net Cash Flow high stood at $41.8 million for FY2021, and its period low was -$106.5 million during FY2022.
- In the last 3 years, Milestone Pharmaceuticals' Net Cash Flow had a median value of $6.1 million in 2023 and averaged -$29.6 million.
- In the last 5 years, Milestone Pharmaceuticals' Net Cash Flow surged by 188.05% in 2021 and then tumbled by 354.61% in 2022.
- Milestone Pharmaceuticals' Net Cash Flow (Yearly) stood at -$47.5 million in 2020, then spiked by 188.05% to $41.8 million in 2021, then crashed by 354.61% to -$106.5 million in 2022, then soared by 105.75% to $6.1 million in 2023, then skyrocketed by 88.67% to $11.6 million in 2024.